Unlocking Legalities: Ninth Circuit Allows Wider Range Of False Claim Suits
Executive Summary
The Ninth Circuit Court of Appeals allowed False Claims Act allegations against drug manufacturers Gilead Sciences to move forward despite a US Supreme Court ruling last year that raised FCA standards.